Cannabinoid withdrawal syndrome is reduced in pre-proenkephalin knock-out mice

Journal of Neuroscience

Volumn 20, Issue 24, 2000, Pages 9284-9289

  Valverde, Olga ^a   Maldonado, Rafael ^a   Valjent, Emmanuel ^a   Zimmer, Anne M ^b   Zimmer, Andreas ^b,c  

^a UNIVERSITAT POMPEU FABRA   (Spain)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Cannabinoid; Mice; Mutation; Opioid; Tolerance; Withdrawal addiction

Indexed keywords

CANNABINOID; DRONABINOL; ENKEPHALIN; PROENKEPHALIN; RIMONABANT;

ABSTINENCE; ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BODY TEMPERATURE; CATALEPSY; CONTROLLED STUDY; FEMALE; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; WITHDRAWAL SYNDROME;

EID: 0034671190     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-24-09284.2000     Document Type: Article

References (42)

1. Interaction between delta 9-tetrahydrocannabinol and morphine on the motor activity of mice
2. Dependence on tetrahydro-cannabinol in rhesus monkeys
3. Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis
4. Mesolimbic dopaminergic decline after cannabinoid withdrawal
5. Case study: Withdrawal syndrome in adolescent chronic cannabis users
6. 1 and CB2 receptors
7. Marijuana's interaction with brain reward systems: Update 1991
8. Cannabinoid transmission and reward-related events
9. 1 receptors
10. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
11. Characterization and localization of cannabinoid receptors m rat brain: A quantitative in vitro autoradiographic study
12. Dynorphin B and spinal analgesia: Induction of antinociception by the cannabinoids CP55,940,Delta(9)-THC and anadamide
13. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membrane
14. Behavioural and biochemical evidence for signs abstinence in mice chronically treated with delta-9-tetrahydrocannabinol
15. Clinical relevance of cannabis tolerance and dependence
16. Naloxone-induced or post-withdrawal abstinence signs in delta9-tetrahydrocannabinol-tolerant rats
17. Opioids: First lessons from knockout mice
18. Pain responses, anxiety and aggression in mice deficient in pre-proenkephalin
19. Neural substrates of opiate withdrawal
20. Opponent process theory of motivation: Neurobiological evidence from studies of opiate dependence
21. 1 receptor knockout mice
22. Absence of opiate rewarding effects in mice lacking dopamine/D2 receptors
23. Opioid-receptor mRNA expression in the rat CNS: Anatomical and functional implications
24. Pharmacological and biochemical interactions between opioids and cannabinoids
25. Quantitative method for assessing one symptom of the withdrawal syndrome in mice after chronic morphine administration
26. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs
27. Marijuana withdrawal syndrome in a woman
28. 1 cannabinoid receptor antagonist-induced opiate withdrawal in morphine-dependent rats
29. Molecular mechanisms of drug addiction
30. Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord
31. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal
32. Interacting brain stem components of opiate-activated, descending, pain-inhibitory systems
33. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappaagonist U-50,488H and attenuates morphine withdrawal
34. Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice
35. 1 cannabinoid receptor knockout mice
36. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism
37. 1 receptors
38. Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine
39. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice
40. An evaluation of the history of a marijuana withdrawal syndrome m a large population
41. Examination of the opioid system using targeted gene deletions
42. 1 receptor knockout mice